Filtered By:
Drug: Actemra
Vaccination: Measles Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 2 results found since Jan 2013.
Long-term immunoprotection after live attenuated measles-mumps-rubella booster vaccination in children with juvenile idiopathic arthritis
CONCLUSION: The MMR booster vaccine demonstrated long-term immunogenicity in the majority of children with JIA from a large cohort, although lower percentages of protective measles antibody levels were observed in bDMARD users. Hence, it might be indicated to measure antibody levels at least five years after MMR booster vaccination in the latter group and advice an extra booster accordingly.PMID:37516575 | DOI:10.1016/j.vaccine.2023.07.052
Source: Vaccine - July 29, 2023 Category: Allergy & Immunology Authors: Mohamad Hamad Saied Joeri W van Straalen Sytze de Roock Gerrie C J de Joode-Smink Frans M Verduyn Lunel Joost F Swart Nico M Wulffraat Marc H A Jansen Source Type: research
